Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane and its associated anionic surface polymers, including teichoic acids in Gram-positive bacteria and lipopolysaccharides in Gram-negative bacteria, constitute a critical structural and functional barrier for the cell (Silhavy et al., 2010). These components maintain cellular integrity, regulate the transport of ions and nutrients, and provide a scaffold for cell wall synthesis enzymes. Because these structures are essential for bacterial survival and possess a high negative charge density not found in mammalian membranes, they serve as selective targets for several classes of antibiotics (Swoboda et al., 2010). Drugs like daptomycin and polymyxins exploit these anionic sites for initial binding before disrupting the underlying lipid bilayer, leading to rapid cell death through depolarization or physical rupture (Humphries et al., 2013; Trimble et al., 2016). Targeting the membrane is particularly effective against slow-growing or persistent bacteria that may be less susceptible to traditional metabolic inhibitors. This target complex is also the primary site of action for many cationic antimicrobial peptides of the innate immune system. Therapeutic challenges include the development of resistance through modifications of surface charge, such as the addition of D-alanine to teichoic acids or aminoarabinose to lipopolysaccharides, which repels cationic drugs.
Antibiotics targeting this complex typically utilize electrostatic attraction to anionic polymers (e.g., teichoic acids or lipopolysaccharides) to concentrate at the bacterial surface, followed by insertion into the phospholipid bilayer, which causes membrane depolarization, pore formation, and leakage of essential intracellular ions like potassium (Humphries et al., 2013; Trimble et al., 2016).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and associated anionic surface polymers.